Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Melting Point | 201.0 | ℃ | 197-205 | ℃ | MSDS |
Water Solubility | 1000.0 | mg/L | <1 | mg/ml | MSDS |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
Absorption | 90.0 | % | 90 | % | DRUGBANK | |
Bioavailability | 88.0 | % | 88 | % | DRUGBANK | |
Metabolic | 15.0 | % | 10-20 | % | Active metabolite; | DRUGBANK |
Clearance | 0.66 | L/h/kg | 11 | ml/min/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution | 1.8 | L/kg | 1.8±0.4 | L/kg | DRUGBANK | |
Volume of Distribution | 1.8 | L/kg | 1.8 | L/kg | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Half-life | 2.3 | h | 2.2-2.3 | h | elimination half-life; | DRUGBANK |
Half-life | 2.7 | h | 2.6-2.8 | h | elimination half-life; | DRUGBANK |
Half-life | 2.2 | h | 2.2 | h | intravenous injection, IV; human, homo sapiens; | Human Intravenous Pharmacokinetic Dataset |
Eliminate Route | 90.0 | % | >90 | % | Urinary excretion; | DRUGBANK |
Protein Binding | 10.0 | % | ~10 | % | plasma proteins; | DRUGBANK |
Not Available